Nexalin Technology, Inc.
NXL- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- SEC CIK
- 0001527352
No open-market purchases or sales by Nexalin Technology, Inc. insiders were filed in the last 90 days; 20 institutions reported holding it in 13F filings for Q2 2026, worth $281.6K in total; no superinvestor holds it.
13F holders, Q3 2025
Institutional positions in Nexalin Technology, Inc. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 20
- 0 vs. Q2 2025
- Shares held
- 695.6K
- −605.1K (−46.5%) vs. Q2 2025
- Total value
- $638.3K
- −$658.4K (−50.8%) vs. Q2 2025
- New holders
- 4
- 4 more added
- Sold out
- 4
- 5 more reduced
1 institution that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NXL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 20 | $281.6K |
| Q1 2026 | 23 | $373.6K |
| Q4 2025 | 19 | $682.6K |
| Q3 2025 | 20 | $638.3K |
| Q2 2025 | 21 | $1.31M |
| Q1 2025 | 17 | $774.5K |
| Q4 2024 | 19 | $1.04M |
| Q3 2024 | 15 | $286.8K |
| Q2 2024 | 13 | $466.9K |
| Q1 2024 | 5 | $88.9K |
| Q4 2023 | 3 | $18.3K |
| Q3 2023 | 5 | $36.0K |
| Q2 2023 | 4 | $11.0K |
| Q1 2023 | 7 | $45.5K |
| Q4 2022 | 7 | $32.5K |
| Q3 2022 | 2 | $21.0K |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding Nexalin Technology, Inc.; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Citigroup Inc | 88 | $81 | 0.00% | +88 | New |
| Bank of America Corp | 135 | $124 | 0.00% | −9−6.3% | Reduced |
| UBS Group AG | 440 | $403 | 0.00% | −14,645−97.1% | Reduced |
| Farther Finance Advisors, LLC | 1,000 | $917 | 0.00% | 00.0% | Unchanged |
| FMR LLC | 1,400 | $1.28K | 0.00% | +1,300+1,300.0% | Added |
| Tower Research Capital LLC (TRC) | 1,431 | $1.31K | 0.00% | −6,091−81.0% | Reduced |
| Rockefeller Capital Management L.P. | 1,500 | $1.38K | 0.00% | +1,500 | New |
| Advisor Group Holdings, Inc. | 2,100 | $2.00K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 3,000 | $3.00K | 0.00% | 00.0% | Unchanged |
| Kingsview Wealth Management, LLC | 10,000 | $9.17K | 0.00% | 00.0% | Unchanged |
| Kovack Advisors, Inc. | 10,050 | $9.22K | 0.00% | 00.0% | Unchanged |
| XTX Topco Ltd | 11,909 | $10.9K | 0.00% | −10,235−46.2% | Reduced |
| Northern Trust Corp | 24,100 | $22.1K | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 29,534 | $27.1K | 0.00% | +29,534 | New |
| State Street Corp | 32,300 | $29.6K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 55,700 | $51.1K | 0.00% | +9,356+20.2% | Added |
| Susquehanna International Group, LLP | 62,498 | $57.3K | 0.00% | +62,498 | New |
| Geode Capital Management, LLC | 121,820 | $111.7K | 0.00% | +5,454+4.7% | Added |
| MYDA Advisors LLC | 150,000 | $137.6K | 0.04% | −650,000−81.3% | Reduced |
| Vanguard Group Inc | 176,582 | $161.9K | 0.00% | +16,704+10.4% | Added |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −37,289−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −11,767−100.0% | Sold out |
| Princeton Global Asset Management LLC | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Morgan Stanley | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Atria Wealth Solutions, Inc. | – | – | – | – | Not filed |